Navigation Links
European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
Date:10/18/2007

- Once Granted by the European Commission, ATRIPLA Would Represent the First and Only Once-Daily Single Tablet Regimen for Many HIV/AIDS Patients

in the European Union -

PRINCETON, N.J., FOSTER CITY, Calif. and WHITEHOUSE STATION, N.J., Oct. 18 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY), Gilead Sciences, Inc. (Nasdaq: GILD) and Merck & Co., Inc. (NYSE: MRK) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion on the Marketing Authorisation Application for ATRIPLA(R) (efavirenz 600mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Specifically, the CHMP has recommended ATRIPLA for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults with virologic suppression to HIV-1 RNA levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. Patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harbored virus strains with mutations conferring significant resistance to any of the three components contained in ATRIPLA prior to initiation of their first an
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. Malvern initiates European user group meetings for chemical imaging
7. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
8. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
9. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
10. Inspire Announces Presentations at Two European Scientific Conferences
11. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 3, 2015 About self-monitoring blood glucose ... home-based electronic device. It consists of a glucose ... glucose levels through radiowaves from the sensor to ... usage of self-monitoring blood glucose devices can improve ... undergo proper diabetes treatment. Technavio,s analysts ...
(Date:9/3/2015)... , Sept. 3, 2015 This Defibrillators ... to save millions of lives across globe. This report ... Kingdom of Saudi Arabia . Stakeholders for ... suppliers, government agencies and regulatory bodies. The ... from two perspectives: by products and by end users. ...
(Date:9/3/2015)... Sept. 3, 2015  WellCare Health Plans, Inc. (NYSE: ... , senior vice president and chief financial officer, is ... Healthcare Conference on Wednesday, September 9, 2015, at 9:25 ... webcast live. In addition, a replay of the webcast ... broadcast. Both the live broadcast and the replay will ...
Breaking Medicine Technology:Global Self-monitoring Blood Glucose Devices Market 2015-2019 2Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... announces that a new market research report is available ... Supergenerics http://www.reportlinker.com/p0350514/Market-Opportunities-for-Supergenerics.html ... payors alike are looking at reducing the prices of ... particularly affected areas where there is strong competition as ...
... MOUNTAIN VIEW, Calif., Dec. 21, 2010 Based ... technologies market, Frost & Sullivan recognizes Cambridge, Mass.-based ... of the Year Award for Surface Functionalization Technologies ... biofunctional surface modification designed to reduce the complications ...
Cached Medicine Technology:Reportlinker Adds Market Opportunities for Supergenerics 2Frost & Sullivan Presents the 2010 North American Enabling Technology of the Year Award for Surface Functionalization Technologies to Semprus BioSciences 2Frost & Sullivan Presents the 2010 North American Enabling Technology of the Year Award for Surface Functionalization Technologies to Semprus BioSciences 3
(Date:9/3/2015)... ... September 03, 2015 , ... ... to Watch for 2015 by economic development group GrowFL and the Edward ... in the state selected for this prestigious award, which recognizes growing second-stage companies ...
(Date:9/3/2015)... ... September 03, 2015 , ... Advice columnist, ... of her debut book, “Stop Wasting Your Time Blaming Others for Your Life.” ... Hartley’s guide to overcoming life’s obstacles by taking full responsibility for one’s life ...
(Date:9/3/2015)... ... September 03, 2015 , ... For the second year ... Inc. 5000 list of fastest-growing private companies in America. President and Editor-in-Chief ... nation's companies have demonstrated such remarkably consistent high growth, particularly in the difficult ...
(Date:9/3/2015)... ... , ... According to an Oncology Nurse Advisor article published on ... oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated for relapses of the ... which have a high rate of success in treatment and elimination of the disease; ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes ... to announce the additional of Carol Wysham, MD, to their esteemed Board of ... Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2
... After a major review of scientific information, six leading ... nicotine reduction strategy should be an urgent research priority ... and disease from tobacco use. Their findings were ... According to this new report, reducing the amount ...
... YORK, October 1, 2010--A multi-institutional team led by investigators ... that provides new insight into genetic changes that make ... primary brain cancer, more aggressive than others and explains ... research was led by senior author Eric C. Holland, ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, ... with ovarian cancer relapse who start chemotherapy as soon as ... significantly longer than women who wait until symptoms begin to ... often precede the reappearance of symptoms in an ovarian cancer ...
... research published in the October edition of the ... the use of chemotherapy in a contemporary, diverse non-small ... Prior population-based studies have shown that only 20 to ... treatment. These studies have previously relied on the Medicare-linked ...
... conducted by University of California, San Diego researchers 14 years ... come with just enough sleep. Less than five hours a ... much. A team of scientists, headed by Daniel F. ... School of Medicine, revisited original research conducted between 1995 and ...
... Ky. The University of Louisville School of Nursing has ... Health and Human Services Health Resources and Services Administration ... graduate nursing students as well as practicing nurses from ... be able to process a tsunami of patient data ...
Cached Medicine News:Health News:Experts urge making cigarettes non-addictive a research priority 2Health News:Researchers discover genetic changes that make some forms of brain cancer more aggressive 2Health News:New Clues to Treating Ovarian Cancer Relapse 2Health News:New Clues to Treating Ovarian Cancer Relapse 3Health News:New lung cancer research finds half of advanced lung cancer patients receive chemotherapy 2Health News:Women's study finds longevity means getting just enough sleep 2Health News:UofL School of Nursing awarded grant to fund new informatics education project 2
Inquire...
Inquire...
... The Tourneau Eyewear Collection was inspired by the ... accessories. It will be appreciated by all men ... 65. The collection incorporates a complete range of ... a retro-flare take advantage of the best that ...
... The collection features a range of ... most modern materials and producted to ... collection includes several super lightweight Titanium ... as a whole host of beautifully ...
Medicine Products: